Build Your Comparison

Side-by-side financial analysis
ACOG logo
ACOG
PRAX logo
PRAX
Try popular comparisons:

Stock Comparison

ACOG vs PRAX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ACOG
Alpha Cognition Inc. Common Stock

Financial - Conglomerates

Financial ServicesNASDAQ • CA
Market Cap$98M
5Y Perf.-4.8%
PRAX
Praxis Precision Medicines, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$7.70B
5Y Perf.+232.5%

ACOG vs PRAX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ACOG logoACOG
PRAX logoPRAX
IndustryFinancial - ConglomeratesBiotechnology
Market Cap$98M$7.70B
Revenue (TTM)$11M$0.00
Net Income (TTM)$-25M$-327M
Gross Margin86.4%
Operating Margin-250.1%
Total Debt$0.00$110K
Cash & Equiv.$66M$357M

ACOG vs PRAXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ACOG
PRAX
StockNov 24Jun 26Return
Alpha Cognition Inc… (ACOG)10095.2-4.8%
Praxis Precision Me… (PRAX)100332.5+232.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: ACOG vs PRAX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PRAX leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Alpha Cognition Inc. Common Stock is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇PRAX emerged as the overall leader. Track its performance:
ACOG
Alpha Cognition Inc. Common Stock
The Banking Pick

ACOG is the clearest fit if your priority is income & stability and growth exposure.

  • beta 1.29
  • EPS growth 42.1%
  • -11.3% 10Y total return vs PRAX's -36.1%
Best for: income & stability and growth exposure
PRAX
Praxis Precision Medicines, Inc.
The Growth Leader

PRAX carries the broadest edge in this set and is the clearest fit for growth and quality.

  • -100.0% revenue growth vs ACOG's -116.5%
  • 2.4% margin vs ACOG's -232.2%
  • +491.9% vs ACOG's -34.4%
Best for: growth and quality
See the full category breakdown
CategoryWinnerWhy
GrowthPRAX logoPRAX-100.0% revenue growth vs ACOG's -116.5%
Quality / MarginsPRAX logoPRAX2.4% margin vs ACOG's -232.2%
Stability / SafetyACOG logoACOGBeta 1.29 vs PRAX's 1.55
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)PRAX logoPRAX+491.9% vs ACOG's -34.4%
Efficiency (ROA)PRAX logoPRAX-40.2% ROA vs ACOG's -41.8%, ROIC -65.0% vs -32.4%

ACOG vs PRAX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ACOGAlpha Cognition Inc. Common Stock
FY 2025
Service
100.0%$433,221
PRAXPraxis Precision Medicines, Inc.
FY 2024
License
76.8%$9M
Upfront Payment
23.2%$3M

ACOG vs PRAX — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLACOGLAGGINGPRAX

Income & Cash Flow (Last 12 Months)

PRAX leads this category, winning 1 of 1 comparable metric.

ACOG and PRAX operate at a comparable scale, with $11M and $0 in trailing revenue.

MetricACOG logoACOGAlpha Cognition I…PRAX logoPRAXPraxis Precision …
RevenueTrailing 12 months$11M$0
EBITDAEarnings before interest/tax-$27M-$357M
Net IncomeAfter-tax profit-$25M-$327M
Free Cash FlowCash after capex-$30M-$283M
Gross MarginGross profit ÷ Revenue+86.4%
Operating MarginEBIT ÷ Revenue-2.5%
Net MarginNet income ÷ Revenue-2.3%
FCF MarginFCF ÷ Revenue-2.8%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-146.2%+2.7%
PRAX leads this category, winning 1 of 1 comparable metric.

Valuation Metrics

Evenly matched — ACOG and PRAX each lead in 1 of 2 comparable metrics.
MetricACOG logoACOGAlpha Cognition I…PRAX logoPRAXPraxis Precision …
Market CapShares × price$98M$7.7B
Enterprise ValueMkt cap + debt − cash$32M$7.3B
Trailing P/EPrice ÷ TTM EPS-5.38x-19.77x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue9.57x
Price / BookPrice ÷ Book value/share1.78x6.83x
Price / FCFMarket cap ÷ FCF
Evenly matched — ACOG and PRAX each lead in 1 of 2 comparable metrics.

Profitability & Efficiency

ACOG leads this category, winning 4 of 7 comparable metrics.

PRAX delivers a -43.0% return on equity — every $100 of shareholder capital generates $-43 in annual profit, vs $-54 for ACOG. On the Piotroski fundamental quality scale (0–9), ACOG scores 4/9 vs PRAX's 3/9, reflecting mixed financial health.

MetricACOG logoACOGAlpha Cognition I…PRAX logoPRAXPraxis Precision …
ROE (TTM)Return on equity-54.1%-43.0%
ROA (TTM)Return on assets-41.8%-40.2%
ROICReturn on invested capital-32.4%-65.0%
ROCEReturn on capital employed-38.4%-49.3%
Piotroski ScoreFundamental quality 0–943
Debt / EquityFinancial leverage0.00x
Net DebtTotal debt minus cash-$66M-$357M
Cash & Equiv.Liquid assets$66M$357M
Total DebtShort + long-term debt$0$110,000
Interest CoverageEBIT ÷ Interest expense
ACOG leads this category, winning 4 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — ACOG and PRAX each lead in 3 of 6 comparable metrics.

A $10,000 investment in ACOG five years ago would be worth $8,873 today (with dividends reinvested), compared to $8,580 for PRAX. Over the past 12 months, PRAX leads with a +491.9% total return vs ACOG's -34.4%. The 3-year compound annual growth rate (CAGR) favors PRAX at 164.8% vs ACOG's -3.9% — a key indicator of consistent wealth creation.

MetricACOG logoACOGAlpha Cognition I…PRAX logoPRAXPraxis Precision …
YTD ReturnYear-to-date-3.1%-6.9%
1-Year ReturnPast 12 months-34.4%+491.9%
3-Year ReturnCumulative with dividends-11.3%+1757.4%
5-Year ReturnCumulative with dividends-11.3%-14.2%
10-Year ReturnCumulative with dividends-11.3%-36.1%
CAGR (3Y)Annualised 3-year return-3.9%+164.8%
Evenly matched — ACOG and PRAX each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ACOG and PRAX each lead in 1 of 2 comparable metrics.

ACOG is the less volatile stock with a 1.29 beta — it tends to amplify market swings less than PRAX's 1.55 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRAX currently trades 72.7% from its 52-week high vs ACOG's 54.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricACOG logoACOGAlpha Cognition I…PRAX logoPRAXPraxis Precision …
Beta (5Y)Sensitivity to S&P 5001.29x1.55x
52-Week HighHighest price in past year$11.54$366.52
52-Week LowLowest price in past year$4.50$37.19
% of 52W HighCurrent price vs 52-week peak+54.6%+72.7%
RSI (14)Momentum oscillator 0–10050.931.9
Avg Volume (50D)Average daily shares traded42K396K
Evenly matched — ACOG and PRAX each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates ACOG as "Buy" and PRAX as "Buy". Consensus price targets imply 127.8% upside for PRAX (target: $607) vs 122.2% for ACOG (target: $14).

MetricACOG logoACOGAlpha Cognition I…PRAX logoPRAXPraxis Precision …
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$14.00$607.15
# AnalystsCovering analysts116
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

PRAX leads in 1 of 6 categories (Income & Cash Flow). ACOG leads in 1 (Profitability & Efficiency). 3 tied.

Best OverallAlpha Cognition Inc. Common… (ACOG)Leads 1 of 6 categories
Loading custom metrics...

ACOG vs PRAX: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is ACOG or PRAX a better buy right now?

Analysts rate Alpha Cognition Inc.

Common Stock (ACOG) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ACOG or PRAX?

Over the past 5 years, Alpha Cognition Inc.

Common Stock (ACOG) delivered a total return of -11. 3%, compared to -14. 2% for Praxis Precision Medicines, Inc. (PRAX). Over 10 years, the gap is even starker: ACOG returned -11. 3% versus PRAX's -36. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ACOG or PRAX?

By beta (market sensitivity over 5 years), Alpha Cognition Inc.

Common Stock (ACOG) is the lower-risk stock at 1. 29β versus Praxis Precision Medicines, Inc. 's 1. 55β — meaning PRAX is approximately 21% more volatile than ACOG relative to the S&P 500.

04

Which is growing faster — ACOG or PRAX?

On earnings-per-share growth, the picture is similar: Alpha Cognition Inc.

Common Stock grew EPS 42. 1% year-over-year, compared to -32. 0% for Praxis Precision Medicines, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ACOG or PRAX?

Praxis Precision Medicines, Inc.

(PRAX) is the more profitable company, earning 0. 0% net margin versus -202. 2% for Alpha Cognition Inc. Common Stock — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRAX leads at 0. 0% versus -221. 7% for ACOG. At the gross margin level — before operating expenses — ACOG leads at 81. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — ACOG or PRAX?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is ACOG or PRAX better for a retirement portfolio?

For long-horizon retirement investors, Alpha Cognition Inc.

Common Stock (ACOG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 29)). Praxis Precision Medicines, Inc. (PRAX) carries a higher beta of 1. 55 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACOG: -11. 3%, PRAX: -36. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between ACOG and PRAX?

These companies operate in different sectors (ACOG (Financial Services) and PRAX (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.